Featured Author Podcast: Danavorexton Promotes Respiration and Wakefulness
Anesthesiology Journal's podcast
Release Date: 05/07/2025
Anesthesiology Journal's podcast
Moderator: BobbieJean Sweitzer, M.D. Participants: Britta Sylvia von Ungern-Sternberg, M.D., Ph.D. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Moderator: James P. Rathmell, M.D. Participants: Lukas Martin Müller-Wirtz, M.D. and Marcos F. Vidal Melo, M.D., Ph.D. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Moderator: BobbieJean Sweitzer, M.D. Participants: Michael Furdyna, M.D. and Grace Lim, M.D., M.Sc. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Creator: James P. Rathmell, M.D., M.B.A. Overview of May issue original studies.
info_outlineAnesthesiology Journal's podcast
Creator: James P. Rathmell, M.D., M.B.A. Overview of April issue original studies.
info_outlineAnesthesiology Journal's podcast
Moderator: James P. Rathmell, M.D. Participants: James O'Carroll, M.B.B.S., and Ruth Landau, M.D. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Moderator: James P. Rathmell, M.D. Participants: Arman Valadkhani, M.D., Ph.D. and Duminda N. Wijeysundera, M.D., Ph.D. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Creator: James P. Rathmell, M.D., M.B.A. Overview of March issue original studies.
info_outlineAnesthesiology Journal's podcast
Moderator: BobbieJean Sweitzer, M.D. Participants: Alparslan Turan, M.D. and Ki Jinn Chin, M.B.B.S., M.Med. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Moderator: James P. Rathmell, M.D. Participants: Mark Bicket, M.D., Ph.D. and Lynn Kohan, M.D. Articles Discussed:
info_outlineModerator: James P. Rathmell, M.D.
Participants: Rebecca L. Wu, M.D. and Max B. Kelz, M.D., Ph.D.
Articles Discussed:
TAK-925 (danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-Induced Respiratory Depression and Sedation Without Affecting Analgesia in Healthy Adult Males
Alluring Potential to Accelerate Emergence and Ameliorate Opioid-induced Respiratory Depression without Antagonizing Analgesia: Danavorexton Enters the Anesthetic Landscape
Transcript